Back to Agenda
Session 5: The Pricing and Reimbursement Perspective
Speaker(s)
Status quo of ATMP Launches in Europe
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
ATMPs from the HTA Viewpoint – Learnings until now
Helen Knight
Programme Director, National Institute for Health and Care Excellence (NICE), United Kingdom
Payer Considerations
Michela Gabaldo, PharmD, MSc
VP ATMP Global Regulatory Affairs, Evotec, Italy
Have an account?